| # | Drug | Count |
|---|---|---|
| 0 | CETUXIMAB | 43 |
| 1 | CISPLATIN | 43 |
| 2 | CARBOPLATIN | 22 |
| 3 | FLUOROURACIL | 22 |
| 4 | FLUOROURACIL CREAM, 0.5% | 22 |
| 5 | DEXAMETHASONE | 12 |
| 6 | DEXAMETHASONE 1.5 MG | 12 |
| 7 | ETOPOSIDE | 10 |
| 8 | ONDANSETRON | 9 |
| 9 | ONDANSETRON HYDROCHLORIDE | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMIFOSTINE | 5 | 0.0062 |
| 1 | CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, URANIUM NITRICUM, X-RAY | 2 | 0.0020 |
| 2 | AVELUMAB | 6 | 0.0015 |
| 3 | CETUXIMAB | 43 | 0.0014 |
| 4 | TAURINE | 1 | 0.0013 |
| 5 | DEXRAZOXANE FOR INJECTION | 1 | 0.0011 |
| 6 | PSYLLIUM HUSK | 1 | 0.0007 |
| 7 | GLUTATHIONE | 1 | 0.0006 |
| 8 | CISPLATIN | 43 | 0.0005 |
| 9 | APREPITANT | 4 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Epidermal Growth Factor Receptor Antagonist [EPC] | 44 | 0.0009 |
| 1 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 3 | 0.0005 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 4 | 0.0005 |
| 3 | Osmotic Diuretic [EPC] | 2 | 0.0004 |
| 4 | Programmed Death Ligand-1 Blocker [EPC] | 6 | 0.0003 |
| 5 | Platinum-based Drug [EPC] | 69 | 0.0003 |
| 6 | Antiseptic [EPC] | 1 | 0.0002 |
| 7 | Selective T Cell Costimulation Blocker [EPC] | 1 | 0.0002 |
| 8 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 9 | Topoisomerase Inhibitor [EPC] | 10 | 0.0001 |